ALFA Finder| Revenue growth | 78.48% YoY growth in FY26 revenue. |
|---|---|
| Margins | EBITDA margin 37.5%; expansion driven by in-house lamination and packaging. |
| Order book | ₹137cr intact; 25% of South African 1B piece tender expected. |
| Demand visibility | Strong; South Africa 1B piece annual tender; global female condom shortage. |
| Management confidence | High; citing niche product status and patented in-house machinery. |
Growth
FY26 revenue ₹137.42cr (+78.48% YoY). H2FY26 revenue ₹83.32cr (+82.77% YoY). Net profit ₹34.30cr (+107% YoY).
Outlook
Guidance to reach ₹1,000cr revenue within 2 years. Capacity expansion to 806M male condoms and 240M female condoms.
Risks
Government payment realization cycles (120+ days); raw material (latex) price volatility during monsoon seasons.
Earnings Call filed with NSE, NSE: ANONDITA. Summary written with AI assistance from the document.
Anondita Medicare Limited: key numbers
- Share price
- ₹1,056.60
- Market cap
- ₹2,012 Cr
- Revenue (annual)
- ₹137.4 Cr
- Net profit (annual)
- ₹33.45 Cr
- P/E (TTM)
- 60.2×Sector 41.3×
- Promoter holding
- 59.26%
- FII holding
- 2.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anondita Medicare Limited
All →Anondita Medicare Bags New Order from Central Medical Services Society, Ministry of Health and Family...
Anondita Medicare received a purchase order from the Central Medical Services Society (Ministry of Health, Govt. of India) to supply 4,20,09,460 condoms. Delivery is due in two tranches within 180 days, with no rupee value disclosed.
- From
- Central Medical Services Society, Ministry of Health and Family Welfare (Government of India)
- Execution
- Tranche I: 50% within 90 days of PO; Tranche II: balance 50% within 91-180 days of PO
Anondita Medicare Business Update
Anondita Medicare appointed six distribution partners across Nepal, Bhutan, and Bangladesh for COBRA condoms and healthcare products. Sales have commenced in Nepal through one partner.
Anondita Medicare Other Announcement
Anondita Medicare Limited has submitted a certificate stating that the compliance report on corporate governance under Regulation 27(2) is not applicable to the company.
Anondita Medicare Annual General Meeting
Anondita Medicare Limited reported the proceedings of its 3rd Annual General Meeting held on September 29, 2026, where several ordinary and special businesses were discussed.
Anondita Medicare Capital Structure Change
Anondita Medicare Limited has reinstated its previous rights issue corrigendum. The issue size is now confirmed at 9,58,166 equity shares, aggregating to ₹91.03 Crore.
- Value
- ₹91.03 Cr
Anondita Medicare Capital Structure Change
Anondita Medicare Limited issued a corrigendum to its Rights Issue, revising the total issue size to ₹91.03 Crore and adjusting the allocation for general corporate purposes.
- Value
- ₹91.03 Cr